Search for a trial

A phase-I open label, balanced, randomized, crossover, two-groups, two-treatments, two-period, pilot study in healthy male subjects to determine the feasibility of a multiple dose dispenser for testosterone intranasal gel as measured by pharmacokinetics

The purpose of this study is to demonstrate the effectiveness of the multiple dose dispenser in comparison to the syringe as measured by a testsoterone pharmacokinetic profile

plasma testosterone levels in hypogonadal individuals treated with AndroGel, impact of showering shortly after application

to investigate whether showering shortly after Androgel application adversly affects plasma testosterone levels.